The Evolution of Antimicrobial Resistance in Respiratory Pathogens in Canada: What are the Clinical Consequences?

by Donald E Low
Published 1998-01-01

Intravenous to Oral Antimicrobial Therapy Stepdown Therapy: Improving the Quality of Care and Reducing Costs

by John M Conly, Donald E Low
Published 1995-01-01

A Prospective Open-Label Multicentre Trial on the Use of 1 G, Once Daily Ceftriaxone in Lower Respiratory Tract Infections

by Donald E Low, Lionel A Mandell
Published 1994-01-01

Launching of the CAN-R Web Site –The Official Web Site of the Canadian Antimicrobial Resistance Alliance

by George G Zhanel, Donald E Low
Published 2007-01-01

The Isolation Rate of Escherichia coli 0157:H7 in Toronto and Surrounding Communities

by Andrew E Simor, Christine Watt, Donald E Low
Published 1990-01-01

Short Course Monotherapy with Clarithromycin for Localized Mycobacterium Marinum Skin Infection

by Mitchell R Weinstein, Donald E Low, Tony Mazzulli
Published 1997-01-01

Comparative Activity of Cefepime with Several Antimicrobials against Aerobic Gram-Negative and Gram-Positive Organisms Isolated from Patients across Canada in 1993

by Donald E Low, The Canadian Antimicrobial Resistance Study Group
Published 1995-01-01

Combining Clinical and Epidemiologic Features for Early Recognition of SARS

by John A. Jernigan, Donald E. Low, Rita F. Helfand
Published 2004-02-01

Biofilms: The Stronghold of Legionella pneumophila

by Mena Abdel-Nour, Carla Duncan, Donald E. Low, Cyril Guyard
Published 2013-10-01

The Threat of the Emergence of Antimicrobial-Resistant Gram-Positive Pathogens in Canada

by Donald E Low, Barbara M Willey, Allison J McGeer
Published 1994-01-01

A Cross-Canada Surveillance of Antimicrobial Resistance in Respiratory Tract Pathogens

by Ross J Davidson, Canadian Bacterial Surveillance Network, Donald E Low
Published 1999-01-01

Comparative Activity of Several Antimicrobial Agents against Nosocomial Gram-Negative Rods Isolated across Canada

by Shelley R Scriver, Canadian Antimicrobial Resistance Study Group, Donald E Low
Published 1995-01-01

Survey of Neisseria gonorrhoeae Antimicrobial Susceptibility in Ontario

by Vivian G Loo, Andrew E Simor, Ruth Jaeger, Donald E Low
Published 1990-01-01

In Vitro Activity of Cefepime against Multidrug-Resistant Gram-Negative Bacilli, Viridans Group Streptococci and Streptococcus pneumoniae from a Cross-Canada Surveillance Study

by Donald E Low, Joyce de Azavedo, Canadian Bacterial Surveillance Network, Ross Davidson
Published 1999-01-01

Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

by Sue Lim, Darrin Bast, Allison McGeer, Joyce de Azavedo, Donald E. Low
Published 2003-07-01

Community-Acquired Antibiotic Resistance in Urinary Isolates from Adult Women in Canada

by Warren J McIsaac, Tony Mazzulli, Joanne Permaul, Rahim Moineddin, Donald E Low
Published 2006-01-01

Phylogenetic incongruence in E. coli O104: understanding the evolutionary relationships of emerging pathogens in the face of homologous recombination.

by Weilong Hao, Vanessa G Allen, Frances B Jamieson, Donald E Low, David C Alexander
Published 2012-01-01

Comparative Evaluation of Seven Commercial Tests for Detection of Heterophile Antibody in Infectious Mononucleosis

by Martin Skulnick, Donald E Low, Andrew E Simor, Mohan Patel, Pauline George, Robert Chua
Published 1992-01-01

Epidemiological Typing of Moraxella Catarrhalis by Pulsed Field Gel Electrophoresis

by Susan M Davison, Donald E Low, Rene H Cruz, Danielle Beaulieu, Shelley R Scriver
Published 1995-01-01

A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology — Results from a Canadian Multicenter Study

by Thomas J Marrie, Donald E Low, Emidio de Carolis, the Canadian Community-Acquired Pneumonia Investigators
Published 2003-01-01